Update on drug importation, February 2026

For over 25 years, well-meaning advocates have proposed importing unauthenticated medicine from foreign countries’ drug supplies to lower prices for Americans. Past efforts didn’t pay off financially and raised public health risks, but legislatures continue to consider state importation schemes while individual employers are turning to importation via alternative funding vendors promising to cut their health insurance costs.

Our February 2026 handout summarizes the situation today. Download it here.